EMA recommends Kygevvi for rare thymidine kinase 2 deficiency. It is the first authorized treatment for this disease.

New York researchers have discovered a way to slow memory loss and boost learning in mice with Alzheimer’s disease. Spring ...

A new study from Cold Spring Harbor Laboratory Professor Nicholas Tonks, graduate student Yuxin Cen, and postdoctoral fellow ...

Two related studies from the University of California, Riverside, have reported that reduced activity of the PTPN2 gene ...

Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...

A hallmark of Parkinson's disease is the buildup of Lewy bodies—misfolded clumps of the protein known as alpha-synuclein.

New York researchers have taken another step in the lengthy battlle against Alzheimer’s disease, finding a way to slow memory ...

A new discovery by researchers from Adelaide University, in collaboration with Denmark's Carlsberg Research Laboratory, will ...

Recently, the research team led by Professor Jun Pang from the Department of Urology at The Seventh Affiliated Hospital of Sun Yat-sen University discovered that cyclin-dependent kinase 12 (CDK12) can ...

Alzheimer's disease is often measured in statistics: millions affected worldwide, cases rising sharply, costs climbing into ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...